Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Renal Failure
  Free Subscription

Articles published in
J Clin Endocrinol Metab
    June 2024
  1. HAN WW, Miao MY, Lyu JQ, Tao HW, et al
    Female reproductive factors, exogenous hormone use, and incident chronic kidney disease and end-stage renal disease.
    J Clin Endocrinol Metab. 2024 Jun 3:dgae374. doi: 10.1210.
    >> Share

    March 2024
  2. LIU JJ, Liu S, Zheng H, Lee J, et al
    Urine tricarboxylic acid cycle metabolites and risk of end stage kidney disease in patients with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Mar 28:dgae199. doi: 10.1210.
    >> Share

    February 2024
  3. AMJAD W, Ginzberg SP, Passman JE, Heintz J, et al
    Predictive Risk Score for Postparathyroidectomy Hungry Bone Syndrome in Patients With Secondary Hyperparathyroidism.
    J Clin Endocrinol Metab. 2024;109:603-610.
    >> Share


  4. Correction to "Hemoglobin Glycation Index: A Novel Risk Factor for Incident Chronic Kidney Disease in an Apparently Healthy Population".
    J Clin Endocrinol Metab. 2024 Feb 8:dgae066. doi: 10.1210.
    >> Share

    January 2024
  5. YU PS, Wu PH, Hung WW, Lin MY, et al
    Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2024 Jan 24:dgae009. doi: 10.1210.
    >> Share

    December 2023
  6. BIOLETTO F, Barale M, Maiorino F, Pusterla A, et al
    Trabecular bone score as a marker of skeletal fragility across the spectrum of chronic kidney disease: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2023 Dec 11:dgad724. doi: 10.1210.
    >> Share

  7. ALI AS, Pham C, Morahan G, Ekinci EI, et al
    Genetic risk scores identify people at high risk of developing diabetic kidney disease: A systematic review.
    J Clin Endocrinol Metab. 2023 Dec 1:dgad704. doi: 10.1210.
    >> Share

    November 2023
  8. LI S, Cui M, Liu Y, Liu X, et al
    Metabolic profiles of type 2 diabetes and their association with renal complications.
    J Clin Endocrinol Metab. 2023 Nov 2:dgad643. doi: 10.1210.
    >> Share

  9. NAKASONE Y, Miyakoshi T, Sakuma T, Toda S, et al
    Hemoglobin Glycation Index, A Novel Risk Factor for Incident Chronic Kidney Disease in Apparently Healthy Population.
    J Clin Endocrinol Metab. 2023 Nov 1:dgad638. doi: 10.1210.
    >> Share

    October 2023
  10. OU SH, Chang WC, Wu LY, Wang SI, et al
    Diabetic macular oedema is predictive of renal failure in patients with diabetes mellitus and chronic kidney disease.
    J Clin Endocrinol Metab. 2023 Oct 6:dgad581. doi: 10.1210.
    >> Share

    August 2023
  11. HUANG PS, Cheng JF, Chen JJ, Wang YC, et al
    Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation.
    J Clin Endocrinol Metab. 2023 Aug 11:dgad448. doi: 10.1210.
    >> Share

    May 2023
  12. FRANCHI M, Gunnarsson J, Gonzales-Parra E, Ferreira A, et al
    Paricalcitol and Extended Release Calcifediol for Treatment of Secondary Hyperparathyroidism in Non-Dialysis Chronic Kidney Disease: Results From a Network Meta-Analysis.
    J Clin Endocrinol Metab. 2023 May 26:dgad289. doi: 10.1210.
    >> Share

  13. RHEE CM, You AS, Narasaki Y, Brent GA, et al
    Development and Validation of a Prediction Model for Incident Hypothyroidism in a National Chronic Kidney Disease Cohort.
    J Clin Endocrinol Metab. 2023 May 15:dgad261. doi: 10.1210.
    >> Share

    March 2023
  14. OIWA A, Hiwatashi D, Takeda T, Miyamoto T, et al
    Efficacy and safety of low-dose spironolactone for chronic kidney disease in type 2 diabetes.
    J Clin Endocrinol Metab. 2023 Mar 14:dgad144. doi: 10.1210.
    >> Share

    December 2022
  15. HAN Q, Xu H
    Letter to the Editor from Han and Xu "Association between DPP4 inhibitor use and the incidence of cirrhosis, ESRD, and some cancers in patients with diabetes".
    J Clin Endocrinol Metab. 2022 Dec 8:dgac693. doi: 10.1210.
    >> Share

  16. LEE DH
    "Response to Letter to the Editor from Han and Xu: Association between DPP4 inhibitor use and the incidence of cirrhosis, ESRD, and some cancers in patients with diabetes".
    J Clin Endocrinol Metab. 2022 Dec 7:dgac697. doi: 10.1210.
    >> Share

  17. JORGENSEN HS, Evenepoel P, Komaba H, Mazzaferro S, et al
    Response to Letter to the Editor from Sumi et al: "Lower bone turnover and skeletal PTH responsiveness in Japanese compared to European patients receiving hemodialysis".
    J Clin Endocrinol Metab. 2022 Dec 5:dgac698. doi: 10.1210.
    >> Share

  18. SUMI H, Shiizaki K, Tominaga N
    Letter to the Editor from Sumi et al: "Lower bone turnover and skeletal PTH responsiveness in Japanese compared to European patients receiving hemodialysis".
    J Clin Endocrinol Metab. 2022 Dec 5:dgac696. doi: 10.1210.
    >> Share

    September 2022
  19. NA Y, Kim SW, Park IB, Choi SJ, et al
    Association between DPP4 inhibitor use and the incidence of cirrhosis, ESRD, and some cancers in patients with diabetes.
    J Clin Endocrinol Metab. 2022 Sep 15. pii: 6701630. doi: 10.1210.
    >> Share

  20. EVENEPOEL P, Jorgensen HS, Komaba H, Mazzaferro S, et al
    Lower bone turnover and skeletal PTH responsiveness in Japanese compared to European patients on hemodialysis.
    J Clin Endocrinol Metab. 2022 Sep 6. pii: 6692465. doi: 10.1210.
    >> Share

    June 2022
  21. SUN Y, Hong L, Huang Z, Wang L, et al
    Fibrosis Risk in Nonalcoholic Fatty Liver Disease is Related to Chronic Kidney Disease in Aged Type 2 Diabetes Patients.
    J Clin Endocrinol Metab. 2022 Jun 29. pii: 6619454. doi: 10.1210.
    >> Share

    May 2022
  22. LASTER ML, Rowan B, Chen HC, Schwantes-An TH, et al
    Genetic Variants Associated with Mineral Metabolism Traits in Chronic Kidney Disease.
    J Clin Endocrinol Metab. 2022 May 19. pii: 6588679. doi: 10.1210.
    >> Share

    March 2022
  23. AU PCM, Tan KCB, Cheung BMY, Wong ICK, et al
    Association between SGLT2 Inhibitors vs DPP4 Inhibitors and Renal Outcomes Among Patients with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2022 Mar 18. pii: 6550649. doi: 10.1210.
    >> Share

  24. KOMABA H, Hamano T, Fujii N, Moriwaki K, et al
    Parathyroidectomy versus cinacalcet among patients undergoing hemodialysis.
    J Clin Endocrinol Metab. 2022 Mar 12. pii: 6547683. doi: 10.1210.
    >> Share

    January 2022
  25. WALLACE AS, Chang AR, Shin JI, Reider J, et al
    Obesity and Chronic Kidney Disease in US Adults With Type 1 and Type 2 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2022 Jan 26. pii: 6511824. doi: 10.1210.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016